Induction of osteogenesis by bone-targeted Notch activation
Authors:
Open Access
- 4 February 2022
- journal article
- research article
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 11
Abstract
Declining bone mass is associated with aging and osteoporosis, a disease characterized by progressive weakening of the skeleton and increased fracture incidence. Growth and lifelong homeostasis of bone rely on interactions between different cell types including vascular cells and mesenchymal stromal cells (MSCs). As these interactions involve Notch signaling, we have explored whether treatment with secreted Notch ligand proteins can enhance osteogenesis in adult mice. We show that a bone-targeting, high affinity version of the ligand Delta-like 4, termed Dll4(E12), induces bone formation in male mice without causing adverse effects in other organs, which are known to rely on intact Notch signaling. Due to lower bone surface and thereby reduced retention of Dll4(E12), the same approach failed to promote osteogenesis in female and ovariectomized mice but strongly enhanced trabecular bone formation in combination with parathyroid hormone. Single cell analysis of stromal cells indicates that Dll4(E12) primarily acts on MSCs and has comparably minor effects on osteoblasts, endothelial cells, or chondrocytes. We propose that activation of Notch signaling by bone-targeted fusion proteins might be therapeutically useful and can avoid detrimental effects in Notch-dependent processes in other organs.Keywords
Funding Information
- Max Planck Society
- European Research Council (AdG 339409 AngioBone)
- European Research Council (AdG 786672 PROVEC)
- Leducq Foundation
This publication has 72 references indexed in Scilit:
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Disorders of Bone RemodelingAnnual Review of Pathology: Mechanisms of Disease, 2011
- The elusive nature and function of mesenchymal stem cellsNature Reviews Molecular Cell Biology, 2011
- Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4The FASEB Journal, 2010
- Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formationJournal of Bone and Mineral Research, 2010
- Jagged1 is a competitive inhibitor of Notch signaling in the embryonic pancreasMechanisms of Development, 2009
- Feasibility of Using a Bone-Targeted, Macromolecular Delivery System Coupled with Prostaglandin E1 to Promote Bone Formation in Aged, Estrogen-Deficient RatsPharmaceutical Research, 2008
- Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiationNature Medicine, 2008
- Dimorphic effects of Notch signaling in bone homeostasisNature Medicine, 2008
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002